The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 13,684 | 323,889 | SH | SOLE | 323,889 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,171 | 2,087,312 | SH | SOLE | 2,087,312 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 11,546 | 1,249,611 | SH | SOLE | 1,249,611 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 42,899 | 3,036,014 | SH | SOLE | 3,036,014 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 4,054 | 292,100 | SH | SOLE | 292,100 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 61,580 | 1,528,031 | SH | SOLE | 1,528,031 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 38,420 | 2,590,680 | SH | SOLE | 2,590,680 | 0 | 0 | ||
| ATRECA INC | CL A COM | 04965G109 | 18,307 | 1,106,180 | SH | SOLE | 1,106,180 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 816 | 13,946 | SH | SOLE | 13,946 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 8,544 | 2,248,300 | SH | SOLE | 2,248,300 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 5,521 | 1,512,627 | SH | SOLE | 1,512,627 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 1,556 | 737,612 | SH | SOLE | 737,612 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 5,145 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 1,294 | 30,510 | SH | SOLE | 30,510 | 0 | 0 | ||
| CYCLERION THERAPEUTICS INC | COM | 23255M105 | 7,267 | 2,742,276 | SH | SOLE | 2,742,276 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 8 | 1,101 | SH | SOLE | 1,101 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 12,224 | 698,101 | SH | SOLE | 698,101 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 61,472 | 3,346,301 | SH | SOLE | 3,346,301 | 0 | 0 | ||
| EXELIXIS INC | COM | 30161Q104 | 108 | 6,269 | SH | SOLE | 6,269 | 0 | 0 | ||
| EXICURE INC | COM | 30205M101 | 4,205 | 2,841,301 | SH | SOLE | 2,841,301 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 52,013 | 2,341,875 | SH | SOLE | 2,341,875 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 30,654 | 882,138 | SH | SOLE | 882,138 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 581 | 256,075 | SH | SOLE | 256,075 | 0 | 0 | ||
| GENMAB A/S | SPONSORED ADS | 372303206 | 13,858 | 653,981 | SH | SOLE | 653,981 | 0 | 0 | ||
| INNATE PHARMA S A | SPONSORED ADS | 45781K204 | 29,831 | 4,465,668 | SH | SOLE | 4,465,668 | 0 | 0 | ||
| IONIS PHARMACEUTICALS INC | COM | 462222100 | 9,863 | 208,609 | SH | SOLE | 208,609 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 44,328 | 4,393,236 | SH | SOLE | 4,393,236 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 34,941 | 3,511,690 | SH | SOLE | 3,511,690 | 0 | 0 | ||
| LIFESCI ACQUISITION CORP | UNIT 03/31/2025 | 53228P208 | 3,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEIRAGTX HOLDINGS PLC | COM | G59665102 | 1,274 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 20,763 | 1,715,962 | SH | SOLE | 1,715,962 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 27,508 | 357,849 | SH | SOLE | 357,849 | 0 | 0 | ||
| MORPHIC HLDG INC | COM | 61775R105 | 41,444 | 2,823,141 | SH | SOLE | 2,823,141 | 0 | 0 | ||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 42,029 | 3,693,203 | SH | SOLE | 3,693,203 | 0 | 0 | ||
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 602 | 264,166 | SH | SOLE | 264,166 | 0 | 0 | ||
| PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 27,407 | 2,248,306 | SH | SOLE | 2,248,306 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 100,865 | 9,426,640 | SH | SOLE | 9,426,640 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 21,405 | 2,536,156 | SH | SOLE | 2,536,156 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM NEW | 75915K200 | 870 | 1,886,812 | SH | SOLE | 1,886,812 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 14,702 | 2,308,079 | SH | SOLE | 2,308,079 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 3,037 | 1,432,664 | SH | SOLE | 1,432,664 | 0 | 0 | ||
| SELECTA BIOSCIENCES INC | COM | 816212104 | 11,080 | 4,597,701 | SH | SOLE | 4,597,701 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 2,383 | 1,274,463 | SH | SOLE | 1,274,463 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 1,180 | 291,997 | SH | SOLE | 291,997 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 16,493 | 371,208 | SH | SOLE | 371,208 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 8,595 | 3,255,813 | SH | SOLE | 3,255,813 | 0 | 0 | ||
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 9,267 | 270,418 | SH | SOLE | 270,418 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 74,747 | 2,501,557 | SH | SOLE | 2,501,557 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 1,034 | 50,809 | SH | SOLE | 50,809 | 0 | 0 | ||
| ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 9,188 | 3,750,000 | SH | SOLE | 3,750,000 | 0 | 0 | ||
| ZYMEWORKS INC | COM | 98985W102 | 1,469 | 41,407 | SH | SOLE | 41,407 | 0 | 0 | ||